MG
TDOC icon

Marex Group’s Teladoc Health TDOC Stock Holding History

Marex Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Sell
18,590
-38,724
-68% -$258K ﹤0.01% 1036
2026
Q1 		$312K Buy
57,314
+8,193
+17% +$46K ﹤0.01% 763
2025
Q4 		$344K Sell
49,121
-3,386
-6% -$26.5K ﹤0.01% 672
2025
Q3 		$406K Sell
52,507
-3,473
-6% -$27.1K ﹤0.01% 555
2025
Q2 		$488K Buy
55,980
+11,013
+24% +$79.8K ﹤0.01% 379
2025
Q1 		$358K Buy
44,967
+857
+2% +$8.67K 0.01% 419
2024
Q4 		$401K Sell
44,110
-2,882
-6% -$27.8K 0.01% 394
2024
Q3 		$431K Sell
46,992
-6,196
-12% -$51.3K 0.01% 317
2024
Q2 		$520K Sell
53,188
-4,697
-8% -$57.3K 0.01% 298
2024
Q1 		$874K Buy
57,885
+4,126
+8% +$74.9K 0.03% 189
2023
Q4 		$1.16M Buy
53,759
+14,770
+38% +$272K 0.05% 209
2023
Q3 		$725K Sell
38,989
-17,378
-31% -$406K 0.1% 90
2023
Q2 		$1.43M Sell
56,367
-2,501
-4% -$62.9K 0.26% 70
2023
Q1 		$1.52M Sell
58,868
-8,893
-13% -$238K 0.2% 80
2022
Q4 		$1.6M Buy
+67,761
New +$1.83M 0.23% 85

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Marex Group's TDOC Position: Q2 2026 in Review

Marex Group reduced its Teladoc Health (TDOC) stake by 68% in Q2 2026, selling an estimated $258K and leaving 18,590 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

Marex Group first reported a position in TDOC in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.6M in Q4 2022. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Marex Group held 18,590 shares of Teladoc Health worth $158K as of Q2 2026.
  • Marex Group sold 38,724 Teladoc Health shares in Q2 2026, an estimated $258K.
  • Teladoc Health made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #1036 holding.
  • Marex Group first reported a position in Teladoc Health in Q4 2022 and has held it in 15 quarters since.
  • Marex Group's Teladoc Health position peaked at $1.6M in Q4 2022.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.